Summary Within a double-blind, cross-above trial, triazolam (0.twenty five mg) was analyzed in opposition to flunitrazepam (1 mg) in the typical midwinter sleeplessness that's typically observed amongst otherwise balanced persons in Northern Norway. Every single drug was provided for five evenings, in random purchase, with a 5-night placebo interva